Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Previously Marketed

6

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

DNA topoisomerase II beta

6

Topoisomerase IV

6

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

6

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1986

6

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Conjunctivitis

6

Gonorrhea

6

Prostatitis

6

Urinary tract infections

6

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Curative

6

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

6

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Kyorin Pharmaceutical

6

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

6

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

6

FDA UNII

6

PUBCHEM

6

EPA CompTox

4

EVMPD

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIINFECTIVES FOR SYSTEMIC USE

1

SENSORY ORGANS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTIBACTERIALS FOR SYSTEMIC USE

1

OPHTHALMOLOGICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIINFECTIVES

1

COMBINATIONS OF ANTIBACTERIALS

1

QUINOLONE ANTIBACTERIALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Combinations of antibacterials

1

Fluoroquinolones

1

Other antiinfectives

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

5

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 6 of 6 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

NORFLOXACIN

N0F8P22L1P

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

NORFLOXACIN GLUTAMATE

E97LKC77WL

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

NORFLOXACIN LACTATE

GU3OE7CPD0

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

NORFLOXACIN HYDROCHLORIDE

7O3ULA741Z

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

NORFLOXACIN MONOHYDRATE

YUF620IF4G

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

NORFLOXACIN SUCCINIL

K40E7MO61Q

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1986

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

DNA topoisomerase II beta

Topoisomerase IV

Conditions:

Urinary tract infections

Norfloxacin is an antibacterial agent, It inhibits inhibits DNA synthesis by inhibiting DNA gyrase enzyme. Norfloxacin was approved in 1986 for treatment of urinary tract infections, gynecological infections, prostatitis, gonorhhea and bladder infect...

ions. In ophtalmology, norfloxacin is used for treatment of conjunctivitus.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1